Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features
Authors:
- 22 November 2002
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 269 (2) , 104-110
Abstract
Introduction. Derailments of the control mechanisms in the G1/S phase of the cell cycle play a fundamental role in the initiation and progression of cancer. However, only a few reports have addressed the issue of simultaneously occurring abnormalities of Rb-pathway components in malignant endometrial tumors. Methods. Currently, we assessed the expression of cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in 48 sporadic endometrial cancers, and investigated these tumors for a possible relationship between aberrant protein staining and clinicopathological variables of cancer and RB-LOH. Results. There was abnormal pRb, cyclin D1, p16INK4A and cdk4 immunoreactivity in 2%, 50%, 6% and 25% of cases, respectively. Altogether, 33 of 48 (69%) endometrial malignant tumors showed abnormal expression of at least one Rb-pathway protein immunohistochemically. However, there was significant correlation neither between the cell-cycle regulators nor between the frequency of pRb, p16INK4A and cyclin D1 abnormalities and clinicopathological variables of cancer, but a significant correlation did exist between cdk4 staining and the clinical stage of disease (Pr=-0.367; P=0.01). However, none of the cell-cycle regulatory proteins, except for pRb, was related to loss of heterozygosity at locus 13q14. Conclusion. As a conclusion, derailments of the Rb-pathway components, cyclin D1 and cdk4 in particular, seems to participate in the endometrial cancer development in humans. Overexpression of cdk4 was related to the progression of neoplastic disease and corresponds with age of onset, suggesting a major role of altered cdk4 immunoreactivity in the progression of endometrial cancer.Keywords
This publication has 36 references indexed in Scilit:
- p27 and Cyclin D1 Abnormalities in Uterine Papillary Serous CarcinomaGynecologic Oncology, 2000
- Developmental defects and tumor predisposition in Rb mutant miceOncogene, 1999
- Retinoblastoma Protein Expression in Endometrial Hyperplasia and CarcinomaGynecologic Oncology, 1997
- p16andp15Alterations in Primary Gynecologic MalignancyGynecologic Oncology, 1997
- Simultaneous expression of the ras p21 and p53 proteins in human endometrial carcinomasActa Histochemica, 1996
- Molecular events in endometrial carcinogenesisInternational Journal of Gynecological Cancer, 1996
- Low frequency of CDKN2 mutation in endometrial carcinomasMolecular Carcinogenesis, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993